Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience


A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Articles from Mary Thompson:

Executive Interviews

BD Spinout embecta Targets Diabetes Market With Three-Pronged Growth Strategy

Diabetes pure play embecta, spun out of BD, is a leading force in the global insulin syringe and pen cap arena, but the company has a comprehensive plan to enter higher-growth device markets, including automated insulin delivery (via a patch pump) and, potentially, smart insulin pens. We discuss the company’s growth strategy at length with CEO Dev Kurdikar.

Read Article